GABARAPL1 and hepatocellular carcinoma: However, in certain cancers, high levels of GABARAPL1 expression are associated with better results, such as hepatocellular carcinoma (HCC) (Berthier et al., 2010) and node-positive breast cancer (Zhang et al., 2018).